Matthew L. Posard, Director at HALOZYME THERAPEUTICS, INC. (HALO), sold 20,000 shares at $50.01 ($1.0M) on 2024-06-11, disclosed to the SEC on 2024-06-13.
Open-market sale of $1.0M HALO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.01 | 10,000 | $500K | 49.7% |
| 2 | $50.62 | 10,000 | $506K | 50.3% |
| Total | $50.31 avg | 20,000 | $1.0M | 100% |
| Filing → |
| HALO | SELL | 2024-08-14 | $2.3M | — | Filing → |
| HALO | SELL | 2022-12-06 | $1.7M | — | Filing → |
| NAUT | BUY | 2021-12-01 | $226K | — | Filing → |